Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

argenx

Biotech & Life Sciences · Ghent, Belgium · Founded 2008 · IPO 2014 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$43B
Market cap · Apr/2026
Revenue
$4.15B
Latest reported FY

Investors

11 investors on argenx's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 7 investors entered at this stage
Omnes Capital
Erasmus MC Biomedical Fund
MVM Life Science Partners
KBC
Thuja Capital
Forbion Capital Partners
BioGeneration Ventures
Series B+ 4 investors entered at this stage
Seventure Partners
PMV
EQT Life Sciences
OrbiMed

Global footprint

Where argenx has talent and traffic

AI talent share
0.5% of workforce is AI talent
(10 of 2,173 staff)
Core AI00%
Other AI100.46%
Non-AI workforce2,16399.54%
Web traffic by country
59K monthly visits
across markets
🇺🇸 United States24.1%
🇧🇪 Belgium15.4%
🇩🇰 Denmark13.7%
🇦🇺 Australia5.6%
🇬🇧 United Kingdom4.9%
Top 5 markets shown

Patent intelligence

$275M patent portfolio · 101 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$275M
0.63% of market cap · 2.8× smaller than top peer BioNTech ($780M)
101 active patent families
Where argenx innovates Molecular biologyAntagonistAntiendomysial antibodiesAntigen bindingAntigen Binding Fragment
Above peer median on Legal, Market

Quality vs same-sector peers

argenx on the five Patsnap quality dimensions

argenx in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where argenx concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across argenx and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See argenx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo